🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Long-term Follow-up Study for Cardiac Safety in the Patients with HER2 Po...
Status
Terminated
Location
Complex Oncological Center - Vratsa, EOOD
Start Date
2016-04
Trial ID
NCT02771795
Treatments Being Tested
This phase II trial compares the effect of usual treatment of docetaxel che...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-03
Trial ID
NCT05408845
Currently there are five trastuzumab biosimilars approved by EMA (Ogivri® M...
Status
Unknown
Location
Centre de lutte contre le Cancer JEAN PERRIN, CLERMONT-FERRAND
Start Date
2020-12
Trial ID
NCT04644406
Treatments Being Tested
This is a study to compare the similarity in Pharmacokinetics (PK) profile ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-03
Trial ID
NCT07601620
Treatments Being Tested
This phase II trial studies how well TPIV100 and sargramostim work in treat...
Status
Unknown
Location
Mayo Clinic in Arizona
Start Date
2020-02-20
Trial ID
NCT04197687
This randomized phase III trial studies docetaxel, carboplatin, trastuzumab...
Status
Completed
Location
Fairbanks Memorial Hospital
Start Date
2014-02-18
Trial ID
NCT02003209
This clinical trial examines an investigational scan (64Cu-DOTA-trastuzumab...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2022-12-21
Trial ID
NCT05376878
To compare the efficacy and safety of PERT-IJS (Proposed biosimilar Pertuzu...
Status
Terminated
Location
Chopda Medicare & Research Centre Pvt. Ltd,
Start Date
2025-01-06
Trial ID
NCT06038539
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested
The purpose of this study is to compare ALT02 (Trastuzumab biosimilar) and ...
Status
Completed
Location
Multiple Locations
Start Date
2016-02-09
Trial ID
NCT03242239
Treatments Being Tested